Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow.

Journal Article

Full Text

Link to Item

Duke Authors

Cited Authors

Lagoo, AS; Gong, JZ; Rizzieri, DA; Stenzel, TT; Chao, NJ; Buckley, PJ

Published Date

November 16, 2001

Published In

Blood

Volume / Issue

98 / 11

Start / End Page

185A - 185A

Published By

AMER SOC HEMATOLOGY

Pages

1

International Standard Serial Number (ISSN)

0006-4971

Language

English